Epstein-Barr virus nuclear antigen-1-dependent and -independent oriP-binding cellular proteins

Intervirology

Volumn 44, Issue 5, 2001, Pages 283-290

  Kusano, Shuichi ^a   Tamada, Keiko ^a   Senpuku, Hidenobu ^a   Harada, Shizuko ^b   Ito, Sayuri ^a   Yanagi, Kazuo ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cellular protein; Epstein Barr virus; Epstein Barr virus nuclear antigen 1; oriP

Indexed keywords

BINDING PROTEIN; BIOTIN; CELL NUCLEUS ANTIGEN; CELL PROTEIN; GLYCEROL; MONOCLONAL ANTIBODY; OLIGONUCLEOTIDE; PROTEIN P45; PROTEIN P64; PROTEIN P72; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; CELL LINE; CENTRIFUGATION; CONTROLLED STUDY; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; FRACTIONATION; LATENT PERIOD; MOLECULAR RECOGNITION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; VIRUS REPLICATION; VIRUS TRANSFORMATION;

BINDING SITES; BURKITT LYMPHOMA; CELL EXTRACTS; CENTRIFUGATION, DENSITY GRADIENT; CONSENSUS SEQUENCE; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN BINDING; REPLICATION ORIGIN; TRANSFECTION; TUMOR CELLS, CULTURED;

HUMAN HERPESVIRUS 4;

EID: 0035742182     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050059     Document Type: Article

References (63)

1. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells
2. Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA
3. Interaction of Epstein-Barr virus nuclear antigen 1 with the viral latent origin of replication
4. Trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1
5. Epstein-Barr virus DNA replication
6. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication
7. Role of the EBNA-1 protein in pausing of replication forks in the Epstein-Barr virus genome
8. Isolation of human sequences that replicate autonomously in human cells
9. Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1
10. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element
11. Rep*: A viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus
12. Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin
13. Origins of DNA replication
14. Replication origins in metazoan chromosomes: Fact or fiction?
15. Regulation of eukaryotic DNA replication
16. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1
17. Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus
18. The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure
19. Constitutive binding of EBNA1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection
20. The linking regions of EBNA1 are essential for its support of replication and transcription
21. The minimal replicator of Epstein-Barr virus oriP
22. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein
23. Epstein-Barr virus
24. Expression of Epstein-Barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428
25. Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus
26. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus
27. Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus
28. EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance
29. Epstein-Barr virus nuclear antigen 1 forms a complex with the nuclear transporter karyopherin alpha2
30. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha
31. Epstein-Barr virus nuclear antigen-1 binds to nuclear transporter karyopherin alpha1/NPI-1 in addition to karyopherin alpha2/Rch1
32. Induction of anti-EBNA-1 protein by 12-O-tetradecanoyl-phorbol-13-acetate treatment of human lymphoblastoid cells
33. Interaction of Epstein-Barr viral (EBV) origin of replication (oriP) with EBNA-1 and cellular anti-EBNA-1 proteins
34. The cellular proteins that bind specifically to the Epstein-Barr virus origin of plasmid DNA replication belong to a gene family
35. Establishemt in continuous culture of a new type of lymphocyte from a 'Burkitt like' malignant lymphoma (line D.G.-75)
36. Induced CD25 expression in a human B-lymphoma cell line transfected with the Epstein-Barr virus nuclear antigen 2 gene
37. Epstein-Barr virus: Transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes
38. Isolation and charcterization of an adherent, 8-azaguanine resistant variant of the Burkitt lymphoma cell line, Raji
39. Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkutt lymphoma cell line
40. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference
41. Concanavalin A receptors on the surface membrane of lymphocytes from patients with African Burkitt's lymphoma and lymphoma cell lines
42. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata
43. Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells
44. Simple repeat array in Epstein-Barr virus DNA encodes part of the Epstein-Barr nuclear antigen
45. Epstein-Barr virus and its replication
46. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region
47. Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA
48. Cooperative assembly of EBNA1 on the Epstein-Barr virus latent origin of replication
49. Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen
50. The Epstein-Barr virus nuclear antigen (BamHI K antigen) is a single stranded DNA binding phosphoprotein
51. DNA sequence and expression of the B95-8 Epstein-Barr virus genome
52. EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles 'RGG' RNA binding proteins
53. Epstein-Barr virus-induced genes: First lymphocyte-specific G protein-coupled peptide receptors
54. Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling protein
55. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes (erratum in J Virol 1996;70: 2678)
56. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin
57. Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells
58. Identification of cellular factors that bind specifically to the Epstein-Barr virus origin of DNA replication
59. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines
60. Kid, a novel kinesin-like DNA binding protein, is localized to chromosomes and the mitotic spindle
61. Mapping EBNA-1 domains involved in binding to metaphase chromosomes
62. A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain
63. Interactions of Epstein-Barr virus origins of replication with nuclear matrix in the latent and in the lytic phases of viral infection